Ocular Therapeutix (OCUL) Net Margin Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53,690.00 |
| Dec 31, 2025 | -27,387.00 |
| Sep 30, 2025 | -19,990.00 |
| Jun 30, 2025 | 74,741.00 |
| Mar 31, 2025 | 10,446.00 |
| Dec 31, 2024 | 73,228.00 |
| Sep 30, 2024 | 267,134.00 |
| Jun 30, 2024 | 326,707.00 |
| Mar 31, 2024 | 392,069.00 |
| Dec 31, 2023 | 329,853.00 |
| Sep 30, 2023 | 287,197.00 |
| Jun 30, 2023 | 198,661.00 |
| Mar 31, 2023 | 387,092.00 |
| Dec 31, 2022 | 254,268.00 |
| Sep 30, 2022 | 278,474.00 |
| Jun 30, 2022 | 409,244.00 |
| Mar 31, 2022 | 322,541.00 |
| Dec 31, 2021 | 234,895.00 |
| Sep 30, 2021 | 183,725.00 |
| Jun 30, 2021 | 240,853.00 |
| Mar 31, 2021 | 230,755.00 |
| Dec 31, 2020 | 248,117.00 |
| Sep 30, 2020 | 2.78 Mn |
| Jun 30, 2020 | 93,389.00 |
| Mar 31, 2020 | 248,997.00 |
| Dec 31, 2019 | 55,586.00 |
| Sep 30, 2019 | 214,690.00 |
| Jun 30, 2019 | 307,992.00 |
| Mar 31, 2019 | 2.18 Mn |